Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase
Status:
Terminated
Trial end date:
2008-08-26
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of LBH589B in adult patients with chronic
myeloid leukemia who are in accelerated phase or blast phase (blast crisis) with resistant
disease following treatment with at least two BCR-ABL tyrosine kinase inhibitors